Real-world data from 24 UK centres for the use of nintedanib for progressive fibrosing interstitial lung disease
Dixon, G; Hague, S; Mulholland, S; et al.Khin, AMN; Thould, H; Connon, R; Minnis, P; Murtagh, E; Khan, F; Toor, S; Lawrence, A; Naqvi, M; West, A; Coker, R; Ward, K; Yazbeck, L; Hart, S; Garfoot, T; Newman, K; Rivera-Ortega, P; Stranks, L; Beirne, P; Bradley, J; Rowan, C; Agnew, S; Ahmad, M; Spencer, LG; Aigbirior, J; Fahim, A; Wilson, AM; Butcher, E; Chong, SG; Saini, G; Zulfikar, S; Chua, F; George, PM; Kokosi, M; Kouranos, V; Molyneaux, P; Renzoni, E; Vitri, B; Wells, AU; Nicol, LM; Bianchi, S; Kular, R; Liu, H; John, A; Barth, S; Wickremasinghe, M; Forrest, IA; Grimes, I; Simpson, AJ; Fletcher, SV; Jones, MG; Kinsella, E; Naftel, J; Wood, N; Chalmers, J; Crawshaw, A; Crowley, LE; Dosanjh, D; Huntley, CC; Walters, GI; Gatheral, T; Plum, C; Bikmalla, S; Muthusami, R; Stone, H; Rodrigues, JCL; Tsaneva-Atanasova, K; Scotton, CJ; Gibbons, MA; Barratt, SL
Date: 27 October 2023
Conference paper
Publisher
European Respiratory Society
Publisher DOI
Clinical and Biomedical Sciences
Faculty of Health and Life Sciences
Item views 0
Full item downloads 0